Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

AnaptysBio Inc buy BTIG Research

AnaptysBio Inc
Start price
€24.80
26.02.24 / 50%
Target price
€50.64
26.02.25
Performance (%)
-35.89%
End price
€15.90
27.02.25
Summary
This prediction ended on 27.02.25 with a price of €15.90. The BUY prediction by BTIG_Research for AnaptysBio Inc performed very badly with a performance of -35.89%. BTIG_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
AnaptysBio Inc 3.219% 3.219% 163.352%
iShares Core DAX® 2.573% 5.333% 8.273%
iShares Nasdaq 100 4.858% 0.449% 27.079%
iShares Nikkei 225® 5.590% -0.586% 48.553%
iShares S&P 500 3.250% 2.500% 23.351%

Comments by BTIG_Research for this prediction

In the thread AnaptysBio Inc diskutieren
Prediction Buy
Perf. (%) -35.89%
Target price 50.644
Change
Ends at 26.02.25

AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at BTIG Research. They set a "buy" rating and a $55.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat

BTIG Research 
0
Report Share
26.02.24
In the thread Trading AnaptysBio Inc
Prediction Buy
Perf. (%) -35.89%
Target price 50.644
Change
Ends at 26.02.25

Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten

BTIG Research 
0
Report Share
27.02.25